Market Highlights

The Middle-East and Africa Stroke Diagnosis and Treatment Market has been evaluated as moderately growing market and it is expected that the market will continue to grow at same pace in the near future. Stroke affects blood supply to brain. Blood vessel that carries oxygen and nutrients to the brain is either blocked by a clot or bursts is the cause of stroke. Due to this brain cells starting to die. Ischemic strokes occur due to narrowing or blocking of arteries to the brain while Hemorrhagic strokes are caused by blood vessels in and around the brain bursting or leaking. There are some symptoms like problem in speaking, inability to move etc. Rising consumer awareness and continuous development of treatment for Stroke Diagnosis and Treatment are driving the growth for the Middle-East and Africa Stroke Diagnosis and Treatment market research. Major drugs and device manufacturers are investing large amount of money for R&D to find cure for Stroke Diagnosis and Treatment. Increasing spending for healthcare, developing infrastructure, and expanded insurance coverage are leading the growth for Middle-East and Africa Stroke Diagnosis and Treatment.

The Stroke Diagnosis and Treatment Market Size to reach a CAGR of 6.5% and a value of USD 289.7 million from 2022 to 2030.There are several factors which are prohibiting the growth of the market such as high cost of treatment and drugs, lack of early treatment, lack of awareness and healthcare facilities particularly in African countries etc.

Stroke Diagnosis and Treatment Market Players:

There are plenty of large and small market players which operates in Middle East and Africa market as well as all over the globe. King Faisal Specialist Hospital and Research Centre (Saudi Arabia), Riyadh Military Hospital (Saudi Arabia), Hamad Medical Corporation (Qatar), American Hospital Dubai, Ganzouri Specialized Hospital (Egypt), Abbott (US), Johnson & Johnson Services, Inc. (US), GE Healthcare (UK), Koninklijke Philips N.V. (Netherlands), Hitachi, Ltd. (Japan)

Regional Analysis:

Considering the Middle-East and Africa Stroke Diagnosis and Treatment Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Stroke Diagnosis and Treatment. Moreover Saudi Arabia market is also growing and second largest market for Stroke Diagnosis and Treatment. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Stroke Diagnosis and Treatment during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.

Segmentation:

Middle-East and Africa Stroke Diagnosis and Treatment market has been segmented on the basis of type which comprise Ischemic strokes, Hemorrhagic strokes, and others.  On the basis of diagnosis the market is segmented into Blood tests, Computerized tomography scan, Magnetic resonance imaging, Carotid ultrasound, cerebral angiogram, Echocardiogram, and Others. On the basis of stroke treatment it is segmented into cerebral thrombosis, Surgical clipping, endovascular embolization, Angioplasty and stents, Surgical AVM removal, Intracranial bypass, Stereotactic radiosurgery, and others. 

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.